-
EP2132169
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2132169
| EP2132169 - NEW METHYLENEBISPHENYL COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.02.2013 Database last updated on 19.10.2024 | Most recent event Tooltip | 08.02.2013 | Application deemed to be withdrawn | published on 13.03.2013 [2013/11] | Applicant(s) | For all designated states Biolipox AB Berzelius väg 3, plan 5 171 65 Solna / SE | [2009/51] | Inventor(s) | 01 /
PELCMAN, Benjamin Biolipox AB Berzelius väg 3, plan 5 S-171 65 Solna / SE | 02 /
NILSSON, Peter Biolipox AB Berzelius väg 3, plan 5 S-171 65 Solna / SE | [2009/51] | Representative(s) | McNeeney, Stephen Phillip Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
| Former [2009/51] | McNeeney, Stephen Phillip Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 08709584.0 | 04.03.2008 | [2009/51] | WO2008GB00724 | Priority number, date | US20070904784P | 05.03.2007 Original published format: US 904784 P | US20070904783P | 05.03.2007 Original published format: US 904783 P | [2009/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008107661 | Date: | 12.09.2008 | Language: | EN | [2008/37] | Type: | A1 Application with search report | No.: | EP2132169 | Date: | 16.12.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.09.2008 takes the place of the publication of the European patent application. | [2009/51] | Search report(s) | International search report - published on: | EP | 12.09.2008 | Classification | IPC: | C07C275/30, C07C275/42, C07C273/18, A61P11/06, A61K31/17, C07C227/08, C07C227/16, C07C227/18, C07C229/58, C07C311/21 | [2009/51] | CPC: |
C07C273/1827 (EP,US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/04 (EP);
A61P11/06 (EP);
A61P13/10 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/04 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/14 (EP);
A61P29/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/24 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07C227/08 (EP,US);
C07C227/16 (EP,US);
C07C227/18 (EP,US);
C07C229/58 (EP,US);
C07C273/1854 (EP,US);
C07C275/30 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2009/51] | Title | German: | NEUE METHYLENBISPHENYLVERBINDUNGEN, DIE SICH FÜR DIE BEHANDLUNG VON ENTZÜNDUNGEN EIGNEN | [2009/51] | English: | NEW METHYLENEBISPHENYL COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION | [2009/51] | French: | NOUVEAUX COMPOSÉS DE MÉTHYLÈNE BISPHÉNYL UTILES DANS LE TRAITEMENT D'UNE INFLAMMATION | [2009/51] | Entry into regional phase | 24.09.2009 | National basic fee paid | 24.09.2009 | Designation fee(s) paid | 24.09.2009 | Examination fee paid | Examination procedure | 22.09.2009 | Amendment by applicant (claims and/or description) | 24.09.2009 | Examination requested [2009/51] | 25.05.2011 | Despatch of a communication from the examining division (Time limit: M04) | 23.09.2011 | Reply to a communication from the examining division | 04.05.2012 | Communication of intention to grant the patent | 15.09.2012 | Application deemed to be withdrawn, date of legal effect [2013/11] | 25.10.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2013/11] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.05.2011 | Fees paid | Renewal fee | 15.03.2010 | Renewal fee patent year 03 | 15.03.2011 | Renewal fee patent year 04 | 27.02.2012 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0488602 (ICI PLC [GB], et al) [A] 1-34 * page 2, line 1 - line 10; example -; claims 1-12 *; | [A]WO03075907 (TIBOTEC PHARM LTD [IE], et al) [A] 1-34 * scheme 5; table 1 *; page 3, line 20 - line 21; claim - *; | [PAD]WO2007113337 (TIBOTEC PHARM LTD [IE], et al) [PAD] 1-34* compounds 14,15,22,26-28 *; | [AD] - LI ET AL, "Discovering novel chemical inhibitors of human cyclophilin A: Virtual screening, synthesis, and bioassay", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, (20060401), vol. 14, no. 7, ISSN 0968-0896, pages 2209 - 2224, XP005297995 [AD] 1-34 * Table 2; Scheme 4; compounds 15,18 * DOI: http://dx.doi.org/10.1016/j.bmc.2005.11.006 | [A] - Y. HAMASAKI ET AL., "(9-[4-acetyl-3-hydroxy-2-n-propylphenoxy) methyl]-3-(1H-tetrazol-5-yl)-4H-pyrido [1, 2a] pyrimidin-4-one), AS-35...", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, USELMSFORD,NY, (2000), vol. 22, pages 483 - 490, XP002446840 [A] 1-34 * Abstract *; paragraphs [02.6] , [0004] * DOI: http://dx.doi.org/10.1016/S0192-0561(00)00010-2 | by applicant | WO2004076640 | WO2005083081 | WO2006092836 | WO2007113337 | - KAO, R. Y. T. ET AL., P. NATL. ACAD. SCI. USA, (2002), vol. 99, no. 15, pages 10066 - 10071 | - JENKINS, J. L., PROTEIN, (2003), vol. 50, pages 81 - 93 | - LI, J. ET AL., BIOORG.' MED. CHEM., (2006), vol. 14, pages 2209 - 2224 |